244 related articles for article (PubMed ID: 23087403)
1. Identification of core DNA elements that target somatic hypermutation.
Kohler KM; McDonald JJ; Duke JL; Arakawa H; Tan S; Kleinstein SH; Buerstedde JM; Schatz DG
J Immunol; 2012 Dec; 189(11):5314-26. PubMed ID: 23087403
[TBL] [Abstract][Full Text] [Related]
2. A critical context-dependent role for E boxes in the targeting of somatic hypermutation.
McDonald JJ; Alinikula J; Buerstedde JM; Schatz DG
J Immunol; 2013 Aug; 191(4):1556-66. PubMed ID: 23836058
[TBL] [Abstract][Full Text] [Related]
3. Control of gene conversion and somatic hypermutation by immunoglobulin promoter and enhancer sequences.
Yang SY; Fugmann SD; Schatz DG
J Exp Med; 2006 Dec; 203(13):2919-28. PubMed ID: 17178919
[TBL] [Abstract][Full Text] [Related]
4. Ig Enhancers Increase RNA Polymerase II Stalling at Somatic Hypermutation Target Sequences.
Tarsalainen A; Maman Y; Meng FL; Kyläniemi MK; Soikkeli A; Budzyńska P; McDonald JJ; Šenigl F; Alt FW; Schatz DG; Alinikula J
J Immunol; 2022 Jan; 208(1):143-154. PubMed ID: 34862258
[TBL] [Abstract][Full Text] [Related]
5. Biased dA/dT somatic hypermutation as regulated by the heavy chain intronic iEmu enhancer and 3'Ealpha enhancers in human lymphoblastoid B cells.
Komori A; Xu Z; Wu X; Zan H; Casali P
Mol Immunol; 2006 Apr; 43(11):1817-26. PubMed ID: 16412510
[TBL] [Abstract][Full Text] [Related]
6. Balancing AID and DNA repair during somatic hypermutation.
Liu M; Schatz DG
Trends Immunol; 2009 Apr; 30(4):173-81. PubMed ID: 19303358
[TBL] [Abstract][Full Text] [Related]
7. Attracting AID to targets of somatic hypermutation.
Tanaka A; Shen HM; Ratnam S; Kodgire P; Storb U
J Exp Med; 2010 Feb; 207(2):405-15. PubMed ID: 20100870
[TBL] [Abstract][Full Text] [Related]
8. Activation-induced cytidine deaminase (AID)-dependent somatic hypermutation requires a splice isoform of the serine/arginine-rich (SR) protein SRSF1.
Kanehiro Y; Todo K; Negishi M; Fukuoka J; Gan W; Hikasa T; Kaga Y; Takemoto M; Magari M; Li X; Manley JL; Ohmori H; Kanayama N
Proc Natl Acad Sci U S A; 2012 Jan; 109(4):1216-21. PubMed ID: 22232677
[TBL] [Abstract][Full Text] [Related]
9. AID preferentially targets the top strand in nucleosome sequences.
Singh AK; Jaiswal A; Kodgire P
Mol Immunol; 2019 Aug; 112():198-205. PubMed ID: 31176199
[TBL] [Abstract][Full Text] [Related]
10. DNA polymerases β and λ do not directly affect Ig variable region somatic hypermutation although their absence reduces the frequency of mutations.
Schrader CE; Linehan EK; Ucher AJ; Bertocci B; Stavnezer J
DNA Repair (Amst); 2013 Dec; 12(12):1087-93. PubMed ID: 24084171
[TBL] [Abstract][Full Text] [Related]
11. Role of activation-induced deaminase protein kinase A phosphorylation sites in Ig gene conversion and somatic hypermutation.
Chatterji M; Unniraman S; McBride KM; Schatz DG
J Immunol; 2007 Oct; 179(8):5274-80. PubMed ID: 17911613
[TBL] [Abstract][Full Text] [Related]
12. Possible contribution of DNase gamma to immunoglobulin V gene diversification.
Okamoto N; Okamoto M; Araki S; Arakawa H; Mizuta R; Kitamura D
Immunol Lett; 2009 Jun; 125(1):22-30. PubMed ID: 19501119
[TBL] [Abstract][Full Text] [Related]
13. Targeting of somatic hypermutation by immunoglobulin enhancer and enhancer-like sequences.
Buerstedde JM; Alinikula J; Arakawa H; McDonald JJ; Schatz DG
PLoS Biol; 2014 Apr; 12(4):e1001831. PubMed ID: 24691034
[TBL] [Abstract][Full Text] [Related]
14. Somatic hypermutation of the AID transgene in B and non-B cells.
Martin A; Scharff MD
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12304-8. PubMed ID: 12202747
[TBL] [Abstract][Full Text] [Related]
15. DNA targets of AID evolutionary link between antibody somatic hypermutation and class switch recombination.
Hackney JA; Misaghi S; Senger K; Garris C; Sun Y; Lorenzo MN; Zarrin AA
Adv Immunol; 2009; 101():163-89. PubMed ID: 19231595
[TBL] [Abstract][Full Text] [Related]
16. Restriction of AID activity and somatic hypermutation by PARP-1.
Tepper S; Mortusewicz O; Członka E; Bello A; Schmidt A; Jeschke J; Fischbach A; Pfeil I; Petersen-Mahrt SK; Mangerich A; Helleday T; Leonhardt H; Jungnickel B
Nucleic Acids Res; 2019 Aug; 47(14):7418-7429. PubMed ID: 31127309
[TBL] [Abstract][Full Text] [Related]
17. Splicing regulator SRSF1-3 that controls somatic hypermutation of IgV genes interacts with topoisomerase 1 and AID.
Kumar Singh A; Tamrakar A; Jaiswal A; Kanayama N; Agarwal A; Tripathi P; Kodgire P
Mol Immunol; 2019 Dec; 116():63-72. PubMed ID: 31622795
[TBL] [Abstract][Full Text] [Related]
18. Topoisomerase I deficiency causes RNA polymerase II accumulation and increases AID abundance in immunoglobulin variable genes.
Maul RW; Saribasak H; Cao Z; Gearhart PJ
DNA Repair (Amst); 2015 Jun; 30():46-52. PubMed ID: 25869824
[TBL] [Abstract][Full Text] [Related]
19. Mutating for Good: DNA Damage Responses During Somatic Hypermutation.
Pilzecker B; Jacobs H
Front Immunol; 2019; 10():438. PubMed ID: 30915081
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanism of immunoglobulin V-region diversification regulated by transcription and RNA metabolism in antigen-driven B cells.
Sakaguchi N; Maeda K; Kuwahara K
Scand J Immunol; 2011 Jun; 73(6):520-6. PubMed ID: 21388430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
